Page 38 - Expanded Access News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Resilience Continues Expansion With Acquisition Of Biologics Manufacturing Company Ology Bioservices SAN DIEGO & BOSTON--(BUSINESS WIRE)-- Resilience (National Resilience, Inc.), a company building the world’s most advanced biopharmaceutical manufacturing ecosystem, announced it has acquired Ology Bioservices, Inc., (Ology Bio) a privately held company that also specializes in biologic drug substance manufacturing from early stage through commercial products. Ology Bio, based in Alachua, Florida, develops and manufactures drugs and biologics for commercial customers as well as the U.S. gove...

Arguments for and against no-excuse absentee/mail-in voting Kevin Kosar, Marc Hyden and Steven Greenhut ( R Street): “Voting absentee or by mail is a safe, trusted and age-old practice. Moreover, expanded access to absentee voting comports with conservative principles, which helps explain why a number of conservative state policymakers have advanced proposals to achieve it. Finally, and critically, policymakers should take note that polling data indicate very clearly that the public strongly favors expanded access to absentee voting and that its results are partisan-neutral.” – “T...

Share this article SAN FRANCISCO, April 13, 2021 /PRNewswire/ -- The global virtual clinical trials market size is expected to reach USD 11.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected  to expand at a CAGR of 5.7% from 2021 to 2028. The need for patient diversity clubbed with enhanced data collection in clinical trials is boosting virtual/decentralized clinical trials (DCTs) market growth. Key suggestions from the report: The oncology segment held 25.0% of the market share in 2020. The increasing adoption of virtual trials especially in ...

Resilience Acquires Ology Bioservices Share Resilience (National Resilience), a biomanufacturing company, acquired Ology Bioservices (Ology Bio), a privately held company that reportedly also specializes in biologic drug substance manufacturing from early stage through commercial products. Ology Bio, based in Alachua, FL, develops and manufactures drugs and biologics for commercial customers as well as the US government, with more than $1.8 billion in government contracts awarded. The acquisition provides Resilience with 300 skilled employees as well as more than 200,000 square feet of manufa...

(1) Independent Data Safety Monitoring Board unanimously recommends continuation of the global Phase 2/3 study of orally-administered opaganib in severe COVID-19 pneumonia based on review of unblinded safety data from the first 255 treated patients The 464-patient global Phase 2/3 COVID-19 study is over 75% enrolled, with completion of enrollment expected in the coming weeks Opaganib potentially minimizes likelihood of resistance due to viral mutations by targeting a human cell component involved in viral replication TEL AVIV, Israel and RALEIGH, N.C., April 9, 2021 /PRNewswire/ -- RedHill Bi...